These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 9595829)

  • 1. [The solubility and in vivo-in vitro correlation of naltrexone].
    Navarro Guerrero J; Ruiz Ramirez JC; Lorduy Oses L
    Boll Chim Farm; 1998 Jan; 137(1):16-20. PubMed ID: 9595829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioavailability of ciprofloxacin tablets in humans and its correlation with the dissolution rates.
    Khan MK; Khan MF; Khan H; Mustafa G
    Pak J Pharm Sci; 2009 Jul; 22(3):329-34. PubMed ID: 19553184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A 'biorelevant' system to investigate in vitro drug released from a naltrexone implant.
    Iyer SS; Barr WH; Dance ME; Coleman PR; Karnes HT
    Int J Pharm; 2007 Aug; 340(1-2):104-18. PubMed ID: 17482393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of in vitro-in vivo correlation of parenteral naltrexone loaded polymeric microspheres.
    Andhariya JV; Shen J; Choi S; Wang Y; Zou Y; Burgess DJ
    J Control Release; 2017 Jun; 255():27-35. PubMed ID: 28385676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple level C in vitro/in vivo correlation of dissolution profiles of two L-thyroxine tablets with pharmacokinetics data obtained from patients treated for hypothyroidism.
    Volpato NM; Silva RL; Brito AP; Gonçalves JC; Vaisman M; Noël F
    Eur J Pharm Sci; 2004 Apr; 21(5):655-60. PubMed ID: 15066666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discrepancy among dissolution rates of commercial tablets as a function of dissolution method. Part 5: In vitro/in vivo correlation for chlorpromazine hydrochloride tablets.
    Ammar HO; Khalil RM; Omar SM
    Pharmazie; 1993 Dec; 48(12):932-5. PubMed ID: 8115438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of a potential medium for 'biorelevant' in vitro release testing of a naltrexone implant, employing a validated stability-indicating HPLC method.
    Iyer SS; Barr WH; Karnes HT
    J Pharm Biomed Anal; 2007 Feb; 43(3):845-53. PubMed ID: 17045445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative bioavailability and in vitro in vivo correlation of two sustained release brands of theophylline: tablets and pellets.
    Tulain U; Ur-Rahman N
    Pak J Pharm Sci; 2008 Apr; 21(2):131-8. PubMed ID: 18390443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation on different levels of in vitro-in vivo correlation: gemfibrozil immediate release capsule.
    Rouini MR; Ardakani YH; Mirfazaelian A; Hakemi L; Baluchestani M
    Biopharm Drug Dispos; 2008 Sep; 29(6):349-55. PubMed ID: 18615873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between in vitro and in vivo parameters of commercial paracetamol tablets.
    Babalola CP; Oladimeji FA; Femi-Oyewo MN
    Afr J Med Med Sci; 2001 Dec; 30(4):275-80. PubMed ID: 14510103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In-vitro and in-vivo correlation for two gliclazide extended-release tablets.
    Mandal U; Ray KK; Gowda V; Ghosh A; Pal TK
    J Pharm Pharmacol; 2007 Jul; 59(7):971-6. PubMed ID: 17637192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo evaluation of 3-O-alkyl ester transdermal prodrugs of naltrexone in hairless guinea pigs.
    Valiveti S; Hammell DC; Paudel KS; Hamad MO; Crooks PA; Stinchcomb AL
    J Control Release; 2005 Feb; 102(2):509-20. PubMed ID: 15653167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A duplex "Gemini" prodrug of naltrexone for transdermal delivery.
    Hammell DC; Hamad M; Vaddi HK; Crooks PA; Stinchcomb AL
    J Control Release; 2004 Jun; 97(2):283-90. PubMed ID: 15196755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Release of naltrexone on buccal mucosa: permeation studies, histological aspects and matrix system design.
    Giannola LI; De Caro V; Giandalia G; Siragusa MG; Tripodo C; Florena AM; Campisi G
    Eur J Pharm Biopharm; 2007 Sep; 67(2):425-33. PubMed ID: 17451927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Naltrexone microspheres: in vitro release and effect on morphine analgesia in mice.
    He GA; Hou HM; Liu XJ
    Acta Pharmacol Sin; 2001 Jun; 22(6):530-3. PubMed ID: 11747760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single- and multiple-dose pharmacokinetics of long-acting injectable naltrexone.
    Dunbar JL; Turncliff RZ; Dong Q; Silverman BL; Ehrich EW; Lasseter KC
    Alcohol Clin Exp Res; 2006 Mar; 30(3):480-90. PubMed ID: 16499489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transfer of naltrexone and its metabolite 6,beta-naltrexol into human milk.
    Chan CF; Page-Sharp M; Kristensen JH; O'Neil G; Ilett KF
    J Hum Lact; 2004 Aug; 20(3):322-6. PubMed ID: 15296587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro dissolution and in vivo oral absorption of methylphenidate from a bimodal release formulation in healthy volunteers.
    Wang Y; Lee L; Somma R; Thompson G; Bakhtiar R; Lee J; Rekhi GS; Lau H; Sedek G; Hossain M
    Biopharm Drug Dispos; 2004 Mar; 25(2):91-8. PubMed ID: 14872557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and validation of a liquid chromatography-mass spectrometry method for the quantitation of naltrexone and 6beta-naltrexol in guinea pig plasma.
    Valiveti S; Nalluri BN; Hammell DC; Paudel KS; Stinchcomb AL
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Oct; 810(2):259-67. PubMed ID: 15380723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dissolution test for citalopram in tablets and comparison of in vitro dissolution profiles.
    Menegola J; Steppe M; Schapoval EE
    Eur J Pharm Biopharm; 2007 Sep; 67(2):524-30. PubMed ID: 17398084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.